Demars Financial Group LLC Sells 134 Shares of The Procter & Gamble Company (NYSE:PG)

Demars Financial Group LLC lessened its stake in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 9.0% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,363 shares of the company’s stock after selling 134 shares during the quarter. Demars Financial Group LLC’s holdings in Procter & Gamble were worth $225,000 as of its most recent filing with the SEC.

A number of other hedge funds have also made changes to their positions in the stock. Advantage Trust Co bought a new position in shares of Procter & Gamble in the fourth quarter worth about $28,000. Naples Money Management LLC bought a new position in Procter & Gamble in the 4th quarter worth approximately $29,000. Transcendent Capital Group LLC acquired a new position in shares of Procter & Gamble during the fourth quarter worth approximately $31,000. Ruedi Wealth Management Inc. boosted its position in shares of Procter & Gamble by 64.7% in the first quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock valued at $32,000 after acquiring an additional 77 shares during the period. Finally, Criterion Capital Advisors LLC acquired a new stake in shares of Procter & Gamble in the fourth quarter worth $33,000. Institutional investors and hedge funds own 65.77% of the company’s stock.

Procter & Gamble Price Performance

Shares of NYSE:PG traded down $0.03 during trading on Friday, reaching $167.89. The stock had a trading volume of 5,640,925 shares, compared to its average volume of 7,681,546. The stock has a market capitalization of $396.24 billion, a PE ratio of 27.43, a P/E/G ratio of 3.66 and a beta of 0.41. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.73 and a quick ratio of 0.53. The Procter & Gamble Company has a 52 week low of $141.45 and a 52 week high of $171.72. The business’s 50-day moving average price is $166.99 and its 200 day moving average price is $163.30.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings data on Tuesday, July 30th. The company reported $1.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.37 by $0.03. The firm had revenue of $20.53 billion during the quarter, compared to the consensus estimate of $20.69 billion. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The business’s revenue for the quarter was down .1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.37 EPS. As a group, equities analysts predict that The Procter & Gamble Company will post 6.97 earnings per share for the current year.

Procter & Gamble Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Friday, July 19th were issued a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a yield of 2.40%. The ex-dividend date of this dividend was Friday, July 19th. Procter & Gamble’s dividend payout ratio is currently 65.85%.

Insider Buying and Selling at Procter & Gamble

In related news, CEO Jon R. Moeller sold 72,174 shares of the business’s stock in a transaction that occurred on Friday, August 9th. The shares were sold at an average price of $171.01, for a total value of $12,342,475.74. Following the completion of the transaction, the chief executive officer now owns 263,158 shares in the company, valued at approximately $45,002,649.58. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, CEO Jon R. Moeller sold 72,174 shares of the firm’s stock in a transaction dated Friday, August 9th. The stock was sold at an average price of $171.01, for a total value of $12,342,475.74. Following the transaction, the chief executive officer now owns 263,158 shares in the company, valued at $45,002,649.58. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Sundar G. Raman sold 31,924 shares of the business’s stock in a transaction dated Monday, May 20th. The stock was sold at an average price of $166.95, for a total value of $5,329,711.80. Following the sale, the chief executive officer now directly owns 19,042 shares of the company’s stock, valued at $3,179,061.90. The disclosure for this sale can be found here. In the last 90 days, insiders sold 116,313 shares of company stock worth $19,703,643. 0.17% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several equities analysts recently commented on the stock. Deutsche Bank Aktiengesellschaft upped their target price on shares of Procter & Gamble from $171.00 to $176.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Evercore ISI increased their target price on shares of Procter & Gamble from $177.00 to $183.00 and gave the company an “outperform” rating in a research note on Thursday, July 18th. Royal Bank of Canada lifted their target price on Procter & Gamble from $157.00 to $164.00 and gave the stock a “sector perform” rating in a research report on Wednesday, July 31st. Jefferies Financial Group cut Procter & Gamble from a “buy” rating to a “hold” rating and cut their price target for the company from $182.00 to $175.00 in a report on Wednesday, July 24th. Finally, Citigroup lifted their price objective on Procter & Gamble from $177.00 to $190.00 and gave the stock a “buy” rating in a report on Wednesday, July 10th. Nine equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $173.95.

Get Our Latest Stock Report on PG

About Procter & Gamble

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

See Also

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.